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Introduction
Activity-dependent changes in synaptic function, known as 
synaptic plasticity, are widely thought as the cellular basis for 
learning and memory (Bliss and Collingridge, 1993). Long-
lasting forms of synaptic plasticity, such as long-term potentia-
tion (LTP) and long-term depression in the hippocampus, are 
now known to rely on the regulated trafficking of -amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)–type 
glutamate receptors (AMPARs) at the postsynaptic membrane 
in response to the activation of N-methyl-d-aspartate (NMDA)–
type glutamate receptors (NMDARs; Malinow and Malenka, 
2002; Kennedy and Ehlers, 2006; Shepherd and Huganir, 2007). 
Over the last two decades, a plethora of protein–protein inter-
actions and enzymatic activities have been described to orches-
trate the intracellular membrane trafficking and targeting of 
these receptors during synaptic plasticity (Huganir and Nicoll, 
2013). In contrast, much less is known of the membrane lipid 
components that participate in this process, particularly as they 
may act both as sensors of neuronal activity and as mediators of 
intracellular trafficking.
Cholesterol is an interesting molecule within this context. 
It participates in multiple cellular functions, including ion chan-
nel function, membrane protein trafficking, and intracellular 
signaling (Dart, 2010; Lippincott-Schwartz and Phair, 2010; 
Simons and Gerl, 2010). Although cholesterol is a ubiquitous 
component of eukaryotic cell membranes, it may play distinct 
functions in the brain because this organ contains 25% of the 
body’s total cholesterol, despite representing 2% of the total 
body’s weight (Dietschy and Turley, 2004). The regulation of 
cholesterol content in the brain is performed in an autono-
mous manner because plasma lipoproteins are prevented from 
crossing the blood–brain barrier (Björkhem and Meaney, 2004). 
Cholesterol levels are regulated in response to strong neuronal 
activity, linked to excitotoxicity and cellular stress (Sodero et al., 
Neurotransmitter receptor trafficking during syn-aptic plasticity requires the concerted action of multiple signaling pathways and the protein trans-
port machinery. However, little is known about the con-
tribution of lipid metabolism during these processes. In 
this paper, we addressed the question of the role of cho-
lesterol in synaptic changes during long-term potentiation 
(LTP). We found that N-methyl-d-aspartate–type gluta-
mate receptor (NMDAR) activation during LTP induction 
leads to a rapid and sustained loss or redistribution of 
intracellular cholesterol in the neuron. A reduction in 
cholesterol, in turn, leads to the activation of Cdc42 and the 
mobilization of GluA1-containing -amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid–type glutamate recep-
tors (AMPARs) from Rab11-recycling endosomes into the 
synaptic membrane, leading to synaptic potentiation. This 
process is accompanied by an increase of NMDAR func-
tion and an enhancement of LTP. These results imply that 
cholesterol acts as a sensor of NMDAR activation and as 
a trigger of downstream signaling to engage small GTP-
ase (guanosine triphosphatase) activation and AMPAR 
synaptic delivery during LTP.
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or after a recovery period of 20 min and compared with control 
(untreated) slices. Liquid chromatography (LC)/mass spectrom-
etry (MS) analysis was used to separately measure cholesterol 
levels in the plasma membrane and microsomal fractions (en-
riched in intracellular membranes; see Materials and methods). 
As shown in Fig. 1 A (left-most graph), no significant change 
was observed in the plasma membrane fraction. In contrast, 
a rapid and sustained decrease in cholesterol content was ob-
served in intracellular membranes (Fig. 1 A, microsomal frac-
tion, left graph). This decrease required NMDAR activation, as 
it was blocked when cLTP was induced in the presence of the 
NMDAR antagonist AP5 (2-amino-5-phosphonopentanoate; 
Fig. 1 A, +AP5 graphs).
To try and visualize this effect, and also to monitor choles-
terol content specifically in neurons, we performed imaging ex-
periments using Bodipy-labeled cholesterol (Hölttä-Vuori et al., 
2008; Marks et al., 2008). Bodipy-cholesterol was injected in 
hippocampal slices in closed proximity to CA1 neurons 24 h 
before the experiment. This long incubation time allows labeled 
cholesterol to equilibrate with the endogenous cholesterol of 
neurons and reach intracellular membranes (Hölttä-Vuori et al., 
2008). Under these conditions, Bodipy-cholesterol was mostly 
observed in what appeared to be intracellular compartments 
(Fig. 1 B, inset). Neurons were then identified on the basis of 
their morphology and localization in the slice. We then imaged 
Bodipy-cholesterol every 5 min before, during, and after cLTP 
induction (see Materials and methods). As a control, similar 
experiments were performed in the presence of AP5, to block 
NMDARs. We observed that Bodipy-cholesterol fluorescence 
rapidly decreased upon cLTP induction (Fig. 1, B and C, blue 
symbols). This decrease was maintained for ≥10 min after the 
end of the induction. This effect was largely blocked in the pres-
ence of AP5, where a slower and less pronounced loss of fluor-
escence was observed (Fig. 1, B and C, black symbols).
Finally, as a third approach to track intracellular choles-
terol content, we monitored the distribution of the cholesterol-
binding domain (D4) of perfringolysin O (Shimada et al., 2002), 
fused to mCherry (Abe et al., 2012). When expressed in hip-
pocampal CA1 neurons, mCherry-D4 displayed a diffuse dis-
tribution with the presence of scattered fluorescence clusters 
(Fig. 1 D, Baseline). These clusters may represent the aggrega-
tion of cholesterol-free protein because extraction of cellular 
cholesterol with methyl--cyclodextrin (MBCD) leads to reduc-
tion of diffuse labeling and proliferation of aggregates (Fig. S1 A) 
that do not generally colocalize with filipin-labeled cholesterol 
(Fig. S1 B). Upon induction of cLTP in hippocampal slices, 
mCherry-D4 distribution rapidly changed, with a reduction of 
diffuse fluorescence and a concomitant increase in cluster inten-
sity (Fig. 1, D and E). These changes were persistent for ≥10 min 
after cLTP induction. This shift from diffuse to clustered dis-
tribution, similar to the one observed upon MBCD cholesterol 
extraction, suggests that cLTP triggers a significant redistribu-
tion of intracellular cholesterol and possibly a net decrease in 
its content. These combined experiments strongly suggest that 
LTP induction triggers a rapid and sustained loss or redistribu-
tion of cholesterol from intracellular compartments in CA1 hip-
pocampal neurons.
2011b, 2012). In addition, changes in cholesterol content have 
been observed during brain aging, as related to neuronal survival 
(Martin et al., 2008; Sodero et al., 2011a; Ledesma et al., 2012) 
and cognitive decline (Martin et al., 2014). In fact, it is being 
increasingly recognized that dysregulation of cholesterol meta-
bolism and homeostasis may have a role in neurological dis-
eases, such as Alzheimer’s (Ledesma and Dotti, 2006; Gamba 
et al., 2012; Suzuki et al., 2013) and Huntington’s (Valenza et al., 
2005). On the other hand, cholesterol may influence multiple 
aspects of synaptic transmission (Pfrieger, 2003), both presyn-
aptically, acting on neurotransmitter vesicle fusion (Deutsch 
and Kelly, 1981; Linetti et al., 2010; Smith et al., 2010; Mercer 
et al., 2012), and postsynaptically, altering neurotransmitter 
receptor diffusion (Renner et al., 2009) and endosomal dy-
namics (Hering et al., 2003; Hou et al., 2008). However, it re-
mains to be established whether cholesterol metabolism is 
regulated by neuronal activity under physiological conditions, 
and particularly, what the molecular mechanisms are that link 
changes in cholesterol to the regulation of synaptic strength 
during plasticity.
In this study, we investigated the regulation of cholesterol 
during synaptic plasticity and its contribution to the modifica-
tion of synaptic function. To this end, we used a combination of 
pharmacological and molecular tools, together with electro-
physiology, biochemistry, and fluorescence imaging. We found 
that LTP induction triggers a decrease in cholesterol content 
specifically from intracellular membranes. Cholesterol removal, 
in turn, leads to the activation of Cdc42 (cell division control 
protein 42 homologue) and facilitates the delivery of AMPARs to 
the synaptic membrane, in a process driven by Rab11-dependent 
trafficking. Therefore, activity-dependent regulation of choles-
terol levels participates in synaptic plasticity by engaging small 
GTPase signaling and driving AMPAR trafficking to the syn-
aptic membrane.
Results
LTP induction reduces cholesterol levels 
from intracellular membranes in neurons
It has been recently shown that glutamate-mediated excitotox-
icity triggers acute cholesterol loss in hippocampal neurons, 
and it was suggested that this may reflect the exaggeration of 
physiological excitatory transmission (Sodero et al., 2012). Here, 
we tested whether NMDAR activation during synaptic plastic-
ity would also be able to regulate cholesterol levels. We used 
three complementary approaches: biochemical quantification of 
endogenous cholesterol, imaging of fluorescently labeled cho-
lesterol derivatives, and monitoring intracellular distribution of 
a cholesterol binding reporter.
LTP was induced on hippocampal slice cultures using 
a well-characterized pharmacological approach that mimics bio-
chemical and electrophysiological properties of electrically 
induced LTP (chemical LTP [cLTP]; Otmakhov et al., 2004; 
Kopec et al., 2006; Arendt et al., 2014). This pharmacological 
approach was used to maximize the number of synapses under-
going plasticity. For biochemical quantification of endogenous 
cholesterol, slices were homogenized just after cLTP induction 
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Figure 1. Cholesterol reduction from intracellular membranes after cLTP induction. (A) Quantification of cholesterol content by LC/MS from hippocampal 
slices immediately after cLTP induction (cLTP), 20 min recovery after cLTP induction (Rec), or from untreated slices (baseline [Bsln]). Cholesterol (Chol) 
content was normalized to major phospholipids (phosphocholine [PC] plus sphingomyelin [SM]) and plotted relative to baseline values. Experiments were 
performed with or without the NMDAR antagonist AP5, as indicated. Symbols connected with lines represent time course experiments performed in paral-
lel. Different lines represent independent experiments. Quantifications were performed from plasma membrane fraction (left) or from microsomal fractions 
(right). Statistical significance was evaluated with the Kruskal–Wallis test. (B) Quantification of Bodipy-cholesterol fluorescence from hippocampal slices 
undergoing cLTP induction (blue-shaded area), with or without AP5, as indicated. Fluorescence values are normalized to the mean fluorescence before 
cLTP induction. n represents the number of cells. Representative images of Bodipy-cholesterol–labeled neurons are shown on the left. (C) Mean values of 
Bodipy-cholesterol fluorescence immediately at the end of the cLTP induction period (cLTP) and after 10-min recovery, from the time course shown in B. The 
p-value was determined with the Mann–Whitney test. n represents the number of cells. (D) Diffuse and clustered mCherry-D4 fluorescence was quantified 
(see Materials and methods) from hippocampal slices undergoing cLTP induction (blue-shaded area). Fluorescence values are normalized to the mean 
fluorescence before cLTP induction. n represents the number of cells. Left shows representative images of a CA1 neuron expressing mCherry-D4 (top) and 
EGFP (bottom), before (Baseline) and after 15-min cLTP induction. (E) Mean values of mCherry-D4 diffuse or clustered fluorescence immediately before 
(Baseline), at the end of the cLTP induction period (cLTP), or after 10 min of recovery, from the time course shown in D. The p-value was determined with 
the Mann–Whitney test. n represent the number of cells. Error bars show means ± SEM. Bars, 10 µm.
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MBCD is only partially specific for cholesterol (Ohtani et al., 
1989) but does not generate additional metabolites, whereas 
Chol Ox is very specific for cholesterol but generates H2O2 and 
a ketone derivative of cholesterol as byproducts. As shown in 
Fig. 2 A, both protocols produced a moderate but significant 
decrease of cholesterol levels in hippocampal slices, as probed 
by a fluorescence enzymatic assay. This decrease was stable 1 h 
after the end of the treatment (Fig. S2 A). Of note, these manip-
ulations initially target plasma membrane cholesterol, but they 
produced a similar reduction of cholesterol from intracellular 
membranes (Fig. 2 B), probably because of the extensive ex-
change between these two pools of cholesterol (Zidovetzki and 
Levitan, 2007). Importantly, this pharmacological reduction in 
Cholesterol removal enhances excitatory 
synaptic transmission
After observing that LTP induction leads to a rapid decrease in 
cholesterol content in CA1 neurons, we decided to test whether 
an acute cholesterol loss may in turn affect synaptic function. 
To this end, we used pharmacological approaches, rather than 
slower genetic interventions or inhibitors of enzymatic activi-
ties, to bypass compensatory effects and/or accumulation of 
intermediary products (Kotti et al., 2006). Endogenous cho-
lesterol was reduced by short time applications (30 min) of 
MBCD (10 mM) or cholesterol oxidase (Chol Ox) enzyme 
(10 U/ml). These two manipulations offer complementary in-
formation to control for potential nonspecific effects because 
Figure 2. Effect of cholesterol removal on 
synaptic function. (A and B) Quantification 
of cholesterol content of hippocampal slices 
treated with cholesterol oxidase (Chol Ox) or 
methyl--cyclodextrin (MBCD) from plasma 
membrane fraction (A) or from microsomal 
fraction (B). Values are normalized to un-
treated (control) slices. n represents number 
of independent experiments. Statistical signifi-
cance is calculated according to the Wilcoxon 
test for slices treated in parallel. (C and D) 
Input resistance (C) and whole-cell capaci-
tance (D) from hippocampal slices treated as 
indicated. n represents the number of cells. 
Statistical significance is calculated according 
to the Mann–Whitney test. (E) Paired-pulse fa-
cilitation (PPF) ratios from whole-cell synaptic 
responses evoked by stimulation with differ-
ent interstimulus intervals (50, 100, 200, and 
400 ms). Hippocampal slices were treated 
as indicated. Representative traces at 50-ms 
interstimulus interval are shown above the 
graph. Bars: (vertical) 50 pA; (horizontal) 50 ms. 
(F) Mean ratio of synaptic responses mediated 
by AMPARs and GABAARs (AMPA/GABA 
ratio). Representative traces are shown above 
the histogram. Bars: (vertical) 50 pA; (horizon-
tal) 10 ms. n represents the number of cells. 
Statistical significance is calculated according 
to the Mann–Whitney test. (G) Cumulative dis-
tribution of mEPSC amplitude from dissociated 
neuronal cultures treated with Chol Ox or un-
treated controls, as indicated. Mean mEPSC 
amplitude from the same data is plotted as a 
histogram in the inset. n represents number of 
miniature responses recorded from four cells 
for each condition. Representative traces are 
shown above the graphs. Bars: (horizontal) 1 s; 
(vertical) 10 pA. (H) Similar to G for mIPSC 
amplitudes. Bars: (horizontal) 1 s; (vertical) 
50 pA. Error bars show means ± SEM.
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cholesterol from intracellular membranes was quantitatively 
similar to the one observed upon cLTP induction (compare 
 Fig. 1 A and Fig. 2 B).
To evaluate the effect of cholesterol decrease on synaptic 
function, we measured CA3-to-CA1 responses in hippocam-
pal slices using whole-cell electrophysiological recordings. 
Importantly, MBCD or Chol Ox treatments did not affect pas-
sive membrane properties of the cell, such as input resistance 
(Fig. 2 C, reflecting cell-wide ion channel conductances and 
membrane integrity), and cell size, as reported by whole-cell 
capacitance (Fig. 2 D). In addition, cholesterol removal did not 
change presynaptic properties of excitatory transmission (as 
assayed by paired-pulse facilitation; Fig. 2 E), or general cell 
viability (MTT assay; Fig. S2 B). Therefore, acute cholesterol 
removal of this magnitude (20–30%) does not appear to have 
any general toxic effect or physiological change in neurons 
from hippocampal slices.
We then measured evoked AMPAR- and -aminobutyric 
acid (GABA) A (GABAA) receptor–mediated responses in CA1 
pyramidal neurons. Ratios of these responses were used for 
normalization to compare potential differential effects on these 
synapses. As shown in Fig. 2 F, AMPA/GABA ratios of synaptic 
responses significantly increased after MBCD or Chol Ox treat-
ments compared with untreated neurons. These results suggest 
that cholesterol removal produces a differential effect at these 
synapses. To dissect specific functional changes at excitatory 
versus inhibitory synapses, we recorded miniature excitatory 
postsynaptic currents (mEPSCs) and miniature inhibitory post-
synaptic currents (mIPSCs) from primary neuronal cultures (see 
Materials and methods). As shown in Fig. 2 G, the treatment 
with Chol Ox produced a marked increase in mEPSC amplitude, 
without any significant effect on mIPSC amplitude (Fig. 2 H). 
All together, these results indicate that cholesterol reduction 
specifically enhances AMPAR-mediated synaptic transmission.
Cholesterol removal induces the delivery of 
new GluA1 at synapses
The combined observation that LTP induction reduces choles-
terol levels and that cholesterol reduction enhances AMPAR- 
mediated synaptic responses, suggests that the activity-dependent 
cholesterol removal may participate in the mechanisms leading 
to synaptic potentiation during LTP. A hallmark of NMDAR-
dependent LTP is the synaptic delivery of GluA1-containing 
AMPARs (Hayashi et al., 2000; Passafaro et al., 2001; Shi et al., 
2001; Boehm et al., 2006; but see also Granger et al., 2013). 
Therefore, we first tested whether AMPARs of specific subunit 
composition are inserted at synapses in response to cholesterol 
removal. To this end, we expressed individual EGFP-tagged 
AMPAR subunits. When overexpressed, these subunits form 
homomeric receptors, which can be detected at synapses by 
their inward rectification properties (Hayashi et al., 2000; Shi 
et al., 2001; in the case of GluA2, we used the rectifying uned-
ited version R607Q).
First, GluA1-EGFP was expressed in organotypic slice 
cultures for 48 h, and synaptic delivery was quantified as an in-
crease in the ratio of the evoked postsynaptic current at 60 mV 
relative to the current at +40 mV (rectification index = I60/I+40), 
in the presence of the NMDAR antagonist AP5. GluA1-EGFP–
expressing neurons display little inward rectification (Fig. 3 A, 
compare first and third columns), in agreement with the obser-
vation that GluA1-containing AMPARs are not efficiently inserted 
at synapses, unless driven by strong synaptic stimulation or 
activation of specific signaling pathways associated to LTP in-
duction (Hayashi et al., 2000; Boehm et al., 2006). In contrast, 
we found that cholesterol reduction in GluA1-EGFP–expressing 
neurons markedly increased the rectification index (Fig. 3 A, 
compare third and fourth columns). This result strongly sug-
gests that cholesterol removal induces synaptic delivery of 
GluA1 AMPARs.
Recombinant GluA2 receptors reach synapses constitutively 
and, therefore, can be used to monitor the cycling population of 
AMPARs (Shi et al., 2001). As expected, when GluA2(R607Q)-
EGFP was expressed, the rectification index was significantly in-
creased compared with nontransfected cells (Fig. 3 A, compare 
first and fifth columns), indicating the presence of the recom-
binant receptor at the synapse. Interestingly, when cholesterol 
was decreased in GluA2(R607Q)-EGFP–expressing neurons, 
this increase in rectification was strongly attenuated (Fig. 3 A, 
compare fifth and sixth columns). This result indicates that the 
proportion of newly inserted (rectifying) GluA2(R607Q)-EGFP 
to endogenous (not rectifying) AMPARs is lower in cholesterol- 
depleted neurons. Of note, this assay reports the relative contri-
bution of recombinant (rectifying) to endogenous (nonrectify-
ing) receptors. Therefore, the observation that cholesterol removal 
increases rectification when the recombinant receptor is homo-
meric GluA1 and decreases it when the recombinant receptor is 
homomeric GluA2(R607Q), strongly suggests that cholesterol 
removal specifically triggers the synaptic insertion of GluA1-
containing AMPARs. Importantly, the treatment with Chol Ox 
did not change the rectification index in the absence of recom-
binant receptors (Fig. 3 A, compare first and second columns), 
indicating that cholesterol removal does not alter the intrinsic 
rectification properties of endogenous AMPARs.
To confirm these results on endogenous AMPARs, we 
performed a double immunostaining of surface and total GluA1 
receptors in dissociated hippocampal neurons (Fig. 3 B). Sur-
face receptors were labeled with an anti–N terminus antibody 
under nonpermeabilized conditions, and total receptors were la-
beled with an anti–C terminus antibody after permeabilization 
(see Materials and methods). Here, acute cholesterol removal 
led to an increase of surface versus total GluA1 expression in 
dendrites when compared with control (Fig. 3, B and C), in 
agreement with our electrophysiology data (Fig. 3 A). Of note, 
total GluA1 expression was not affected by cholesterol removal, 
as probed by Western blotting on dissociated neurons and or-
ganotypic hippocampal cultures (Fig. 3, D and E). Collectively, 
these results indicate that cholesterol removal enhances excit-
atory synaptic transmission by inducing the delivery of new 
GluA1-containing AMPARs at the postsynaptic membrane.
Synaptic potentiation induced by 
cholesterol removal is mediated by Rab11
To ascertain the delivery route for AMPARs, we assessed the 
involvement of Rab11-dependent trafficking, which mediates 
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of Rab11 (Rab11-S25N; Ullrich et al., 1996). Evoked AMPAR-
mediated synaptic responses were simultaneously recorded from 
nearby pairs of CA1 neurons expressing EGFP-Rab11-DN and 
uninfected neurons (Fig. 4 A, scheme). As previously published 
(Gerges et al., 2004), overexpression of EGFP-Rab11-DN 
the activity-dependent delivery of GluA1-containing AMPARs 
from intracellular compartments into synapses during LTP 
(Park et al., 2004; Brown et al., 2007). To evaluate the role of 
Rab11 in AMPAR synaptic delivery upon cholesterol removal, 
we used a well-characterized dominant-negative (DN) version 
Figure 3. Cholesterol removal induces surface delivery and synaptic insertion of GluA1 AMPARs. (A) AMPAR-mediated responses were recorded at 60 
and +40 mV, from hippocampal slices expressing GluA1-EGFP, GluA2(R607Q)-EGFP, or not infected, with or without Chol Ox treatment, as indicated. The 
rectification index was calculated as the ratio of responses at these holding potentials (I60mV/I+40mV). Representative traces are shown above the histogram. 
Bars: (vertical) 50 pA; (horizontal) 10 ms. n represents the number of cells. The p-value was determined using the Mann–Whitney test. (B) Representa-
tive images of primary hippocampal neuronal cultures treated as indicated and immunostained for surface and total GluA1 expression. Bottom images 
represent zoomed-in images from top boxes. Bars: (top) 20 µm; (bottom) 5 µm. (C) Quantification of surface over total expression of GluA1 from dendritic 
branches as the ones shown in B. Values are normalized to untreated neurons. n represents number of cells out of three independent experiments. Statistical 
significance was calculated using the Mann–Whitney test. (D) Western blot analysis of GluA1 levels from hippocampal slices or from dissociated primary 
neuronal cultures, treated as indicated. Tub, tubulin. (E) Quantification of total GluA1 levels from n independent experiments as the one shown in D. Error 
bars show means ± SEM.
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has no significant effect on synaptic AMPAR currents under 
basal conditions (Fig. 4 B). In contrast, neurons overexpres-
sing EGFP-Rab11-DN exhibit smaller AMPAR currents than 
their neighboring uninfected neurons upon cholesterol removal 
(Fig. 4 C). These results indicate that Rab11-DN blocks the po-
tentiation of AMPAR currents produced by acute cholesterol 
Figure 4. Synaptic potentiation induced by cholesterol removal requires Rab11 and Cdc42 activity. (A) Schematic representation of the experimental 
configuration for paired, simultaneous recordings of AMPAR synaptic responses from infected (green) and uninfected (white) CA1 neurons. SC, Schaffer 
collaterals. (B and C) Mean AMPAR-mediated synaptic responses from pairs of uninfected (Uninf.) or Rab11-DN-EGFP–expressing neurons, from untreated 
hippocampal slices (B) or treated with Chol Ox (C). Representative traces are shown above the histogram. Bars: (vertical) 50 pA; (horizontal) 10 ms. 
Statistical significance is calculated according to the Wilcoxon test. (D) Pull-down from organotypic slice culture extracts with GST-Pak3-CRIB under control 
conditions and after cholesterol removal by Chol Ox or MBCD treatment. Total and GTP-bound Cdc42 was detected by immunoblotting with specific 
antibodies to Cdc42. Tubulin was used as a loading control. (E and F) Quantification of active Cdc42-GTP (E) or total Cdc42 (F) levels from slices treated 
for cholesterol removal or from untreated controls, as indicated. Results from Chol Ox and MBCD treatments were similar, and they have been pooled to-
gether. The ratios of GTP-bound and total Cdc42 were normalized to untreated controls. n represents the number of pairwise comparisons between treated 
and nontreated slices. Statistical significance is calculated according to the Wilcoxon test. (G and H) Similar to B and C for EGFP-Cdc42-DN–expressing 
neurons. Error bars show means ± SEM.
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Figure 5. Cholesterol removal enhances NMDAR synaptic currents and LTP. (A) Time course of normalized AMPAR-mediated synaptic responses before 
and after LTP induction, from control slices or slices treated with Chol Ox. LTP was induced at time = 0 min. Sample traces recorded before (thin line) and 
after (thick line) LTP induction are shown on the right. Bars: (vertical) 50 pA; (horizontal) 10 ms. (B) Quantification of mean synaptic potentiation from paired 
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in CA1 neurons with a standard pairing protocol (Hayashi 
et al., 2000). As shown in Fig. 5 (A and B), LTP induction 
significantly increased AMPAR-mediated responses in both 
cholesterol-depleted and untreated neurons. Nevertheless, the 
reduction in cholesterol content enhanced LTP expression two-
fold compared with untreated neurons. Therefore, these data 
indicate that reduced levels of cholesterol facilitate NMDAR-
dependent LTP.
These results were counterintuitive because we had ob-
served that cholesterol removal induces AMPAR synaptic de-
livery in a process mechanistically similar to LTP (involving 
the GluA1 subunit and Rab11 trafficking). Therefore, we ex-
pected that LTP and synaptic potentiation induced by cho-
lesterol removal may occlude each other. On the other hand, it 
has also been shown that oxysterols may directly modulate 
NMDR function (Linsenbardt et al., 2014). We then tested whether 
cholesterol removal was affecting NMDAR-mediated synap-
tic responses and, in this manner, may alter LTP induction. To 
this end, we performed similar experiments to those shown in 
Fig. 2 F, but measuring NMDA/GABA ratios (without Mg2+ 
and in the presence of CNQX to block AMPAR responses). As 
shown in Fig. 5 C, cholesterol removal produced a significant 
increase in NMDA/GABA ratio. Given our previous observa-
tion that cholesterol reduction does not alter GABA transmis-
sion (Fig. 2 H), this result indicates that cholesterol removal 
induces an increase of NMDAR synaptic currents, as it does for 
AMPAR responses.
Because cholesterol removal enhances NMDAR func-
tion and facilitates LTP, we then hypothesized that this may 
contribute to the AMPAR synaptic delivery we had observed. 
Therefore, we tested whether GluA1 synaptic delivery upon 
cholesterol removal requires NMDAR activation. GluA1 de-
livery was examined by monitoring inward rectification (as de-
scribed for Fig. 3 A) while blocking NMDARs during the acute 
removal of cholesterol. We found that application of 100 µM 
AP5 completely blocked the increase in rectification produced 
by cholesterol removal (AP5 was present 1 h before and dur-
ing cholesterol removal; Fig. 5 D). Therefore GluA1 synaptic 
delivery triggered by cholesterol removal requires NMDAR 
activity. Altogether, these data indicate that cholesterol reduc-
tion enhances NMDAR synaptic responses and facilitates the 
synaptic delivery of AMPARs in an LTP-like process.
depletion. Thus, we conclude that Rab11-dependent trafficking 
mediates the synaptic delivery of AMPARs triggered by choles-
terol removal.
Cholesterol depletion activates Cdc42, which 
mediates AMPAR synaptic potentiation
It has been recently shown that LTP induction triggers the acti-
vation of the small GTPase Cdc42 (Murakoshi et al., 2011) and 
that this activation is required for synaptic potentiation (Kim 
et al., 2014). We therefore tested whether a similar mechanism 
may be operating upon cholesterol reduction. We first evalu-
ated whether cholesterol removal alters Cdc42 activation in 
hippocampal slices. To this end, we treated hippocampal slices 
with Chol Ox or with MBCD, as described for Fig. 2. Then, 
the amount of active (GTP bound) Cdc42 was measured with 
a standard pull-down assay with GST-Pak3–Cdc42/Rac inter-
active binding (CRIB; Hansen and Nelson, 2001). As shown in 
Fig. 4 (D and E), cholesterol reduction produced a significant 
activation of Cdc42 in hippocampal extracts, without altering 
total levels of Cdc42 (Fig. 4 F).
Then, we tested whether Cdc42 activation was required 
for AMPAR synaptic delivery triggered by cholesterol removal. 
Similar to the experiments in Fig. 4 (B and C), we expressed 
a well-characterized DN form of Cdc42 (T17N; Hansen and 
Nelson, 2001) in CA1 hippocampal neurons and measured its 
effect on synaptic transmission with and without cholesterol 
removal. As shown in Fig. 4 G, Cdc42-DN did not alter AMPAR 
synaptic transmission under control conditions. In contrast, 
in Chol Ox–treated slices, Cdc42-DN significantly depressed 
AMPAR responses (Fig. 4 H). These results imply that Cdc42-
DN blocks the enhancement of AMPAR responses induced by 
cholesterol removal. Therefore, we conclude that AMPAR syn-
aptic potentiation requires Cdc42 activation.
Cholesterol reduction enhances NMDAR 
currents and facilitates LTP
Given the parallelisms between AMPAR synaptic delivery 
triggered by LTP induction and by cholesterol removal, we 
decided to test whether cholesterol content affects this form 
of synaptic plasticity. As in our previous experiments, slices 
were pretreated with Chol Ox for 30 min, and LTP was induced 
and unpaired pathways from the last 10 min of the time course shown in A (for the unpaired pathway, one stimulating electrode is turned off during LTP 
induction). The p-value was determined with the Mann–Whitney test. n, number of cells. (C) Mean NMDA/GABA ratios calculated from synaptic responses 
recorded in the presence of CNQX and in the absence of Mg2+, at 60 mV for NMDARs and at 0 mV for GABAARs. Hippocampal slices were treated 
with Chol Ox or left untreated (control). Representative traces are shown above the histograms. n represents the number of cells. Statistical significance is 
calculated according to the Mann–Whitney test. (D) Rectification experiments similar to the ones described in Fig. 3 A, from slices expressing GluA1-EGFP 
and treated with Chol Ox in the presence of AP5 (NMDAR inhibitor). Data from slices without AP5 are replotted from Fig. 3 A. n represents number of cells, 
and p-value was determined with the Mann–Whitney test. Representative traces are shown above the histogram. Bars: (vertical) 50 pA; (horizontal) 10 ms. 
(E) mRNA analysis by quantitative RT-PCR for Grin1, Grin2A, and Grin2B (GluN1, GluN2A, and GluN2B, respectively) from slices treated with Chol Ox 
or MBCD. Values are normalized to untreated slices. n represents number of independent experiments. (F) Western blot analysis of GluN1 expression 
from whole extracts of hippocampal slices treated with Chol Ox or MBCD. Values are normalized to untreated slices. n represents number of independent 
experiments. A representative blot is shown on the left. Tub, tubulin. (G, left). Mean trace of NMDAR response, obtained from the same recordings as in C, 
normalized to its peak amplitude from control and Chol Ox–treated slices. SEM is plotted for each trace as thin dashed lines. (right) Mean half-decay 
time (t1/2) of NMDA responses from the same data plotted on the left. (H) Mean NMDAR-mediated synaptic responses from pairs of uninfected (Uninf.) or 
EGFP-Rab11-DN–expressing neurons, from untreated hippocampal slices (left) or treated with Chol Ox (right). Representative traces are shown above the 
histogram. Bars: (vertical) 50 pA; (horizontal) 10 ms. Statistical significance is calculated according to the Wilcoxon test. (I) Similar to H, with pairs of 
uninfected and Cdc42-DN–expressing neurons. Error bars show means ± SEM.
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Synaptic potentiation of NMDARs by 
cholesterol removal requires Rab11-dependent 
trafficking but not Cdc42 activation
These last results suggest that cholesterol, besides being regu-
lated downstream from NMDAR activation (Fig. 1), also acts 
as upstream regulator of NMDAR function. We then investi-
gated the mechanisms by which cholesterol removal enhances 
NMDAR function.
It has been previously shown that cholesterol reduction 
triggers TrkB activation (Martin et al., 2008), and TrkB signal-
ing has been linked to enhanced NMDAR transcription (Caldeira 
et al., 2007). Therefore, we tested whether cholesterol removal 
from hippocampal slices would alter NMDAR mRNA levels. 
As shown in Fig. 5 E, RT-PCR analysis from hippocampal slices 
treated with Chol Ox did not detect any significant changes 
in mRNA levels for NMDAR subunits (Grin1, Grin2A, and 
Grin2B, corresponding to GluN1, GluN2A, and GluN2B pro-
teins, respectively). In addition, Western blot analysis also failed 
to detect changes in NMDAR protein expression upon choles-
terol removal (Fig. 5 F).
Changes in the subunit composition of synaptic NMDARs 
may also have important consequences for synaptic plasticity 
(Liu et al., 2004). To address this issue, we evaluated the kinet-
ics of NMDAR synaptic responses because currents mediated 
by GluN2A- or GluN2B-containing NMDARs are character-
ized by different decay times (Monyer et al., 1994). As shown 
in Fig. 5 G, the decay times of NMDA responses were not 
significantly altered by cholesterol removal, arguing against 
changes in subunit composition.
We then asked whether potentiation of NMDAR re-
sponses induced by cholesterol removal was mediated by Rab11-
dependent trafficking and/or Cdc42 activity, as was the case for 
AMPARs. As shown in Fig. 5 (H and I), neither Rab11-DN nor 
Cdc42-DN altered NMDAR synaptic transmission under control 
conditions. In contrast, Rab11-DN (Fig. 5 H), but not Cdc42-
DN (Fig. 5 I), depressed NMDAR responses after cholesterol 
removal. These results suggest that NMDAR synaptic potentia-
tion induced by cholesterol reduction is mediated by Rab11- 
dependent trafficking, but it does not require Cdc42 activity.
Cholesterol addition impairs LTP
Our results shown here suggest that cholesterol loss may be 
an intrinsic mechanism mediating LTP expression. To test this 
hypothesis, we aimed to prevent cholesterol reduction during 
LTP induction by applying a saturating amount of cholesterol 
in complex with MBCD. MBCD-cholesterol inclusions readily 
exchange cholesterol with cellular membranes (Christian et al., 
1997) and, therefore, will buffer potential changes in cholesterol 
levels. We then performed LTP experiments, similar to Fig. 5 A, 
comparing slices treated with MBCD-cholesterol versus vehi-
cle control (0.1% ethanol). As shown in Fig. 6 (A and B), LTP 
induction significantly increased AMPAR-mediated responses 
in controls neurons. In contrast, LTP was completely absent in 
cholesterol-treated neurons.
Figure 6. Effect of cholesterol addition on 
LTP and NMDAR synaptic responses. (A) Time 
course of normalized AMPAR-mediated synap-
tic responses before and after LTP induction, 
from slices treated with the MBCD–cholesterol 
(Chol/MBCD) complex or vehicle control 
(0.1% ethanol), as indicated. LTP was induced 
at time = 0 min, by pairing presynaptic 3-Hz 
stimulation (300 pulses) with postsynaptic 
depolarization (0 mV). Sample traces re-
corded before (thin line) and after (thick line) 
LTP induction are shown above the graph. 
(B) Quantification of mean synaptic potentia-
tion from the last 10 min of the time course 
shown in A. The p-value was determined with 
the Mann–Whitney test. n, number of cells. 
(C) Time course of normalized NMDAR- 
mediated synaptic responses (recorded in the 
presence of CNQX and in the absence of 
Mg2+), during addition of MBCD–cholesterol 
(area shaded in magenta). Representative 
traces before (thin line) and after MBCD–
cholesterol treatment (thick line) are shown 
above the graph. Bars: (horizontal) 10 ms; 
(vertical) 10 pA. (D) Quantification of mean 
synaptic depression from the last 10 min of 
the time course shown in C. The p-value was 
determined with the Wilcoxon test, compar-
ing before and after MBCD–cholesterol treat-
ment for each cell. n represents number of 
cells. Error bars show means ± SEM.
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An important insight from this work is that NMDAR acti-
vation during LTP induction triggers a rapid reduction in intra-
cellular cholesterol. Several neurodegenerative disorders such 
as Huntington’s (Valenza et al., 2010) or Alzheimer’s disease 
(Ledesma and Dotti, 2006; Gamba et al., 2012), as well as age-
ing (Ledesma et al., 2012), have been associated with altera-
tions in cholesterol metabolism. Reductions in cholesterol levels 
have also been observed upon excitotoxic stimuli (Sodero et al., 
2012). Nevertheless, to our knowledge, this is the first study of 
an acute modulation of neuronal cholesterol induced by physio-
logical synaptic activity, namely, LTP induction. The mechanism 
responsible for this cholesterol change remains to be determined, 
but it is intriguing that the reduction occurred preferentially at 
intracellular membranes (as reported with both biochemical and 
imaging methods). Of note, intracellular compartments con-
tain only a small fraction of total cellular cholesterol (Lange et al., 
1989). Therefore, changes in cholesterol turnover (Sodero 
et al., 2012) as well as subcellular redistribution (Hölttä-Vuori 
et al., 2002) may be responsible for this acute reduction in intra-
cellular cholesterol.
In this study, we have also addressed the functional con-
sequences of this reduction in cholesterol. Intracellular choles-
terol is preferentially associated to recycling endosomes (Hao 
et al., 2002, 2004), and it has been proposed that this pool of 
cholesterol favors intracellular retention of raft-associated pro-
teins (Mayor et al., 1998). Therefore, it is tempting to speculate 
that a localized depletion of cholesterol will favor the mobiliza-
tion of internalized proteins. This may be related to the Rab11-
dependent synaptic enhancement that we have observed for both 
AMPARs and NMDARs. Nevertheless, the synaptic targeting 
of these two types of receptors is not mechanistically equiva-
lent. Thus, AMPAR synaptic potentiation required both Rab11 
and Cdc42 activity, suggesting that besides mobilization of re-
cycling endosomes, this process engages additional signaling 
This result supports the interpretation that cholesterol re-
moval is a necessary step for LTP expression. However, NMDAR 
function itself may be regulated by cholesterol, as it has been 
shown for oxysterols (Linsenbardt et al., 2014). To test this pos-
sibility, we acutely added MBCD-cholesterol while monitoring 
NMDAR synaptic responses. As shown in Fig. 6 C, cholesterol 
addition produced a rapid and pronounced rundown of NMDA 
responses, which stabilized at 50% depression. Although this 
result does not necessarily contradict the interpretation that cho-
lesterol removal is required for LTP expression, we cannot rule 
out that NMDAR depression is at least partially responsible for 
the LTP impairment shown in Fig. 6 (A and B).
Discussion
In this study, we propose that cholesterol has a dual function 
during synaptic plasticity (Fig. 7, schematic representation). On 
the one hand, a reduction in intracellular cholesterol constitutes 
an intermediate step downstream from LTP induction, linking 
NMDAR signaling with the activation of Cdc42 and the synap-
tic trafficking of AMPARs (Fig. 7, right elements). On the other 
hand, cholesterol levels modulate NMDAR trafficking and, in 
this manner, are upstream regulators of LTP induction (Fig. 7, 
left elements). The role of cholesterol as a downstream media-
tor of LTP is based on three main lines of evidence. First, induc-
tion of NMDAR-dependent LTP produces a sustained decrease 
or redistribution in cholesterol content, preferentially from intra-
cellular compartments. Second, pharmacological reduction of 
cholesterol levels leads to the activation of Cdc42. Third, this 
activation is required for the delivery of AMPARs into the syn-
aptic membrane, in a process mediated by Rab11-dependent 
trafficking. The role of cholesterol as an upstream regulator of 
NMDAR function would be mechanistically different. It also 
relies on Rab11-dependent trafficking but is independent from 
Cdc42 signaling.
Diverse (and often conflicting) results have been reported 
for the synaptic effects of manipulating cholesterol levels. Strong 
depression of basal synaptic transmission and LTP impairment 
has been observed upon cholesterol reduction with cyclodextrin 
(Frank et al., 2008). In contrast, LTP enhancement and no effect 
on basal transmission were reported with a statin inhibitor of 
cholesterol biosynthesis (Mans et al., 2010). However, the op-
posite effect (LTP impairment) was observed using a different 
statin (Kotti et al., 2006). We cannot aim to explain this diver-
gent literature. Nevertheless, we do want to emphasize that this 
study stems from the observation of an endogenous reduction of 
cholesterol upon synaptic plasticity induction. As for the phar-
macological manipulations, we have obtained consistent results 
using cholesterol extraction methods (cyclodextrin treatment) 
as well as enzymatic degradation (Chol Ox), and we report the 
actual cholesterol reduction obtained with these methods. Fi-
nally, by evaluating AMPAR-, NMDAR-, and GABAA receptor 
(GABAAR)–mediated currents, as well as LTP expression, in 
hippocampal slices, we are able to present a coherent scenario, 
in which activity-dependent changes in cholesterol mediate in-
tracellular signaling for AMPAR synaptic delivery, and further 
modulate NMDAR function.
Figure 7. Schematic representation of cholesterol regulation during LTP 
and participation in synaptic plasticity mechanisms. NMDAR activation 
upon LTP induction leads to the loss of cholesterol from intracellular mem-
branes. This in turn leads to the activation of Cdc42 and the mobilization 
of Rab11-dependent trafficking. These two events, together with further 
downstream signaling from NMDARs, are required for AMPAR synaptic 
delivery and potentiation of synaptic transmission (right side of the cartoon). 
In contrast, enhancement of NMDAR responses is mediated by Rab11 but 
does not require Cdc42 activation (left side of the cartoon).
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these constructs, EGFP is fused in frame at the N terminus of the protein. 
For protein expression, all coding sequences (GluA1-EGFP, GluA2-EGFP, 
EGFP-Rab11-DN, and EGFP-Cdc42-DN) were cloned in pSinRep5 for the 
preparation of Sindbis virus. This is a neurotropic plus-strand RNA virus, 
which acts as an mRNA inside the cell, leading to high protein expres-
sion with low toxicity for ≤72 h after infection (Ehrengruber et al., 1999; 
Malinow et al., 2010). Protein expression was 36–48 h for GluA1-EGFP 
and GluA2-EGFP and 12–24 h for EGFP-Rab11-DN and EGFP-Cdc42-DN. 
Because only CA1 cells (and not CA3 cells) were infected, this configura-
tion ensured that recombinant proteins were always expressed exclusively 
in the postsynaptic cell.
Cholesterol quantification
LC/MS (Fig. 1 A). Hippocampal slices were rapidly washed in cold PBS and 
then homogenized in a lysis buffer containing 25 mM MES, 2 mM EDTA, 
and cocktails of protease and phosphatase inhibitors from Roche. Typi-
cally, 10 slices were used for each experimental point. After centrifugation 
at 100,000 g, both pellet fraction (containing mostly plasma membrane 
cholesterol) and supernatant (microsomal fraction containing mostly intra-
cellular membranes) were analyzed separately. Lipid extraction and quan-
tification of lipid phosphorus was performed as previously published (Bligh 
and Dyer, 1959; Rouser et al., 1970). In brief, tissue fractions are resus-
pended in a 1:2 mixture of chloroform/methanol. This is then diluted with 
a 1:1 mix of chloroform/water. After phase separation, the chloroform layer 
contains all lipids. Lipid phosphorus is then analyzed by two-dimensional 
thin-layer chromatographic separation of polar lipids and analysis of spots. 
Phospholipid content of cell extracts was determined by LC/MS on a mass 
spectrometer (4000-QTRAP; AB Sciex). Temperature was set to 475°C, 
nebulizer gas was set to 60 at an inlet pressure of 5 bar, and a needle cur-
rent was set to 1 µA. Declustering potential was set to 65 V. Full scan spec-
tra were collected in the range from 400 to 1,050 amu at a scan speed of 
4,000 amu/s. Relative response factors of lipid classes were determined using 
authentic standards as external calibrants (Brouwers et al., 2013). Cholesterol 
was analyzed essentially as described previously, using 4-cholesten-3-one 
as an internal standard (Brouwers et al., 2011). In brief, 5 µl lipid extract, 
containing 250 pmol cholesterol and 4-cholesten-3-one as an internal 
standard, was injected on a 50 × 4.6–mm hydrophilic interaction liquid 
chromatography column (Phenomenex) and eluted at a flow rate of 1 ml/min. 
Thus separating free cholesterol from its esterified counterpart, free choles-
terol was quantified by monitoring the transition from 369.3/161.1 amu 
and comparing its signal to that of the coeluting internal standard (transi-
tion 385.4/109.2 amu) with correction for their respective response factors 
and using a dwell time of 50 ms.
For cLTP experiments, hippocampal slices were transferred for 5 min 
to a submersion-type holding chamber containing artificial cerebrospinal 
fluid (ACSF) gassed with 5% CO2/95% O2 at room temperature. For cLTP 
induction, slices were transferred for 15 min to a separate chamber con-
taining 0.1 µM Rolipram, 50 µM Forskolin, and 100 µM Picrotoxin in ACSF 
lacking MgCl2. After the induction period, some slices were transferred to 
a chamber containing regular ASCF, for a recovery period of 20 min. After 
these treatments, slices were immediately homogenized and processed for 
cholesterol quantification.
Colorimetric assay (Fig. 2, A and B). Hippocampal slices were rapidly 
washed in cold PBS and then homogenized in a lysis buffer containing 
25 mM MES, 2 mM EDTA, and cocktails of protease and phosphatase 
inhibitors obtained from Roche. After suspension, samples were spun at 
100,000 g for 2 h at 4°C. Pellet (plasma membrane fraction, resuspended 
in PBS containing 0.1% SDS) and supernatant (microsomal fraction) were 
analyzed in parallel. Protein amount was quantified by Bradford Bicincho-
ninic Acid Assay kit obtained from Thermo Fisher Scientific, and the cho-
lesterol content was measured per microgram of protein using the Amplex 
Red Cholesterol Assay kit obtained from Invitrogen.
Fluorescence imaging for cholesterol quantification
Organotypic hippocampal slices where either injected with 10 µM Bodipy-
cholesterol (provided by R. Bittman, City University of New York, New 
York, NY) and left incubating for 12–24 h to allow equilibration with 
endogenous cholesterol, or biolistically transfected (“gene gun”) with 
mCherry-D4 and EGFP for 24 h to allow expression of the recombinant 
proteins. The mCherry-D4 plasmid was a gift from T. Kobayashi (RIKEN 
Advanced Science Institute, Saitama, Japan). Both mCherry-D4 and EGFP 
are expressed under the control of the cytomegalovirus promoter, using 
the pEGFP plasmid backbone from Takara Bio Inc. Confocal images were 
acquired with a confocal microscope (LSM510; Carl Zeiss) using a 63×, 
NA 1.2 water immersion objective and 488- and 543-nm lasers, at 29°C. 
events (Kim et al., 2014). In contrast, NMDAR potentiation 
upon cholesterol removal may represent a more passive conse-
quence of mobilizing an extrasynaptic pool of NMDARs. In the 
case of AMPAR synaptic delivery, the involvement of Cdc42 is 
particularly interesting because this small GTPase is activated 
upon LTP induction (Murakoshi et al., 2011) and is required 
for synaptic potentiation and spine structural plasticity (Kim 
et al., 2014). The mechanisms leading to Cdc42 activation upon 
cholesterol removal are not completely clear. They may be 
related to the displacement of Cdc42 from lipid rafts (Fessler 
et al., 2004; Jaksits et al., 2004). Interestingly, concomitant 
Cdc42 activation and mobilization of Rab11 recycling endo-
somes has been observed in hepatic cells upon cholesterol re-
moval (Xie et al., 2011). Additionally, reduction in cholesterol 
levels has been linked to the activation of the phosphoinositide 
3-kinase pathway (Martin et al., 2008, 2011), which may in 
turn lead to Cdc42 activation via phosphatidylinositol (3,4,5)-
trisphosphate–sensitive Cdc42 GEFs, such as Vav2 and Vav3 
(Aoki et al., 2005).
In conclusion, cholesterol reduction downstream from 
NMDAR activation would trigger two separate events: mobili-
zation of intracellular AMPARs via Rab11-dependent synaptic 
trafficking and activation of Cdc42 for actin remodeling and 
structural plasticity. These two events are necessary for AMPAR 
synaptic potentiation (Fig. 7). Nevertheless, full LTP expres-
sion would require additional signaling events triggered down-
stream from NMDARs because pharmacological removal of 
cholesterol is not sufficient to induce AMPAR synaptic potenti-
ation without concomitant NMDAR activation (Fig. 7). Alto-
gether, our data reveal the existence of a dynamic interplay 
between cholesterol levels in neurons and synaptic activity and 
provide a mechanistic link between activity-dependent choles-
terol changes, AMPAR trafficking, and synaptic plasticity.
Materials and methods
Ethics statement
All biosafety procedures and animal care protocols were approved by the 
bioethics committee from the Consejo Superior de Investigaciones Cientifi-
cas and were performed according to the guidelines set out in the Euro-
pean Community Council Directives (86/609/EEC).
Neuronal cultures and recombinant protein expression
Organotypic hippocampal slice cultures were prepared as previously de-
scribed (Gähwiler et al., 1997). In brief, hippocampal slices are prepared 
from young rats (postnatal days 5–7), placed in culture on semipermeable 
membranes in a medium containing 20% horse serum, 1 mM l-glutamine, 
1 mM CaCl2, 2 mM MgSO4, 1 mgl1 insulin, 0.0012% ascorbic acid, 30 mM 
Hepes, 13 mM d-glucose, and 5.2 mM NaHCO3, and maintained at 35.5°C. 
Culture medium was replaced with a fresh one every 2–3 d. The slices were 
used at 5–6 d in vitro for most experiments and ≤8 d for LTP experiments. 
Primary dissociated hippocampal neurons were prepared as previously 
described (Goslin and Banker, 1989). In brief, hippocampi are extracted 
from rat fetuses at embryonic day 19, and dissociated neurons are plated 
on glass coverslips coated with 1 mg/ml of poly-l-lysine. Cultures are main-
tained at 37°C in Neurobasal medium (Gibco) supplemented with B27 
(Gibco) and glutamine and used at 14 d in vitro.
DNA constructs for the expression of GluA1-EGFP and GluA2-EGFP 
were generated in the laboratory of R. Malinow (University of California, 
San Diego, San Diego, CA). In these constructs, EGFP is fused in frame 
immediately downstream from the signal peptide of GluA1 and GluA2 
(Shi et al., 2001). DN forms of Rab11 (S25N) and Cdc42 (T17N) were 
previously described (Hansen and Nelson, 2001; Gerges et al., 2004). In 
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gelatin in PBS for 30 min. For labeling surface GluA1, neurons were incu-
bated for 1 h with an antibody against the GluR1 N terminus (mouse 
monoclonal; Santa Cruz Biotechnology, Inc.). Total GluA1 was then immuno-
detected after a permeabilization step (30-min incubation in 0.1% Triton 
X-100 and 0.2% gelatin in PBS) with an antibody against the GluR1 C ter-
minus (rabbit polyclonal; Abcam). Corresponding secondary antibodies 
(goat anti–mouse or goat anti–rabbit) conjugated with Alexa Fluor 488 
and Alexa Fluor 555 (Life Technologies) were incubated for 45 min. Cov-
erslips were mounted in FluorSave reagent (EMD). Cells were imaged 
using an epifluorescence microscope (Axiovert 200; Carl Zeiss). Quantifi-
cation was performed using ImageJ software. Regions of interest corre-
sponding to individual dendrites were manually selected on the total GluA1 
channel. Therefore, image quantification was essentially blind with respect 
to the surface GluA1 channel. All intensities were corrected for background 
labeling. For illustration of representative pictures (Fig. 3 B), image editing 
was performed using ImageJ and was limited to background subtraction 
and linear contrast enhancement.
Protein biochemistry
Slices were homogenized in a lysis buffer containing 10 mM Hepes, pH 
7.4, 150 mM NaCl, 10 mM EDTA, 1% Triton X-100, and cocktails of 
protease and phosphatase inhibitors obtained from Roche (Complete Mini 
EDTA-free and phosSTOP). Protein amount was quantified by Bradford 
Bicinchoninic Acid Assay kit and analyzed by SDS-PAGE and Western 
blotting with an anti-GluA1 antibody (rabbit polyclonal; Abcam) or anti-
Cdc42 antibody (mouse monoclonal; BD). For the Cdc42 activation assay, 
GTP loading on Cdc42 was determined with a GST-Pak3-CRIB pull-down 
before Western blotting with the anti-Cdc42 antibody (Rodriguez-Fraticelli 
et al., 2010). Western blots were developed with chemiluminescence, 
and images were analyzed using ImageJ software.
Quantitative RT-PCR
Total RNA from slices were extracted with TRIzol reagent (Ambion/Life Tech-
nologies) following the manufacturer’s procedures and cleaned up using 
RNeasy Mini kit (QIAGEN). RNA was quantified by absorbance at 260 nm 
 using a NanoDrop ND-100 (Themo Fisher Scientific). Retrotranscription to 
first-strand cDNA was performed using RevertAid H Minus First Strand cDNA 
Synthesis kit (Themo Fisher Scientific). In brief, 5 ng of synthesized cDNA 
was used to perform the quantitative PCR using GoTaq quantitative PCR 
Master Mix (Promega) in a sequence detection system (ABI PRISM 7900HT; 
Applied Biosystems; Life Technologies). The primers purchased from Sigma-
Aldrich were used at 0.5 µM final concentration to detect transcripts for 
Grin1 forward, 5-CCATTGTTCAAGAGGGTGCT-3, and reverse, 5-GTC-
ACTCCGTCCGCATACTT-3; Grin2A forward, 5-GCAAGCCACAGTTATGC-
TGA-3; and reverse, 5-AGACGTGCCAGTCGTAGTCC-3; and Grin2B  
forward, 5-CCGAAGCTGGTGATAATCCT-3; and reverse, 5-ACCCTCT-
CCCACTTCCTCTC-3. Three housekeeping genes Gapdh, GusB, and Pgk1 
were used as endogenous controls.
mCherry-D4 and filipin imaging on human embryonic kidney (HEK) cells
HEK cells were plated onto poly-l-lysine–coated coverslips and cultured at 
37°C in DMEM (Gibco) supplemented with 10% of fetal bovine serum. Cells 
were transfected with mCherry-D4 plasmid using a calcium/phosphate pro-
tocol and let for protein expression during 12–24 h. For mCherry-D4 live 
imaging, cells were imaged in Tyrode’s buffer (30 mM glucose, 120 mM 
NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, and 25 mM Hepes) with a 
confocal microscope (LSM510) using a 40×, NA 1.3 objective and 543-nm 
laser, at 25°C. Images were reconstructed using ImageJ software. For fili-
pin staining, cells were fixed with 4% paraformaldehyde and 4% sucrose 
in PBS, for 10 min at room temperature. Nonspecific binding was blocked 
with 0.2% horse serum (Gibco) in PBS for 30 min. Cells were then incubated 
for 1.5 h with filipin (Sigma-Aldrich) at 50 µg/µl in the blocking solution. 
Coverslips were mounted in FluorSave reagent. Cells were imaged with 
a LSM510 confocal microscope using a 40×, NA 1.3 objective and 543-nm 
(mCherry) and 405-nm (filipin) lasers. Images were reconstructed using 
ImageJ software.
MTT cell viability assay
Slices were first incubated for 30 min at room temperature with Chol Ox or 
MBCD in ASCF as previously described. Slices were then incubated in 
ACSF with 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) for 1.5 h. Slices were then homogenized in DMSO, and cell 
viability was evaluated with the MTT reduction method, measuring the ab-
sorbance at 595 nm and subtracting background absorbance at 665 nm, 
using a Microplate Reader (Model 550; Bio-Rad Laboratories). As a positive 
Fluorescence was collected as z stacks using Zen software (Carl Zeiss). 
For cLTP experiments, slices were perfused with ASCF. Baseline images 
were acquired every 5 min during 15 min, and then, the perfusion solu-
tion was switched to ACSF containing 0.1 µM Rolipram, 50 µM Forskolin, 
and 100 µM Picrotoxin, and without MgCl2. After a 15-min treatment, 
slices were perfused again with standard ACSF for a 10-min recovery 
period. For some slices, all perfusion solutions contained 100 µM AP5 to 
block NMDARs. For Bodipy-cholesterol image quantification, regions of 
interest corresponding to individual dendrites were manually selected. For 
mCherry-D4 image quantification of the diffuse fraction, regions of interest 
were drawn in the soma. For mCherry-D4 cluster quantification, clusters 
were first defined by applying a threshold on images filtered with a Lapla-
cian of Gaussian (LoG3D) plugin for ImageJ software (National Institutes 
of Health). The sum of integrated fluorescence intensity contained in these 
clusters was then quantified from the unfiltered images. All intensities were 
corrected for background signal. Images were reconstructed and analyzed 
using ImageJ software.
Manipulations of cholesterol content
Cholesterol removal. Organotypic slices were incubated for 30 min at room 
temperature in the dark with 10 U/ml Chol Ox (EMD Millipore) or 10 mM 
MBCD (Sigma-Aldrich) in a submersion-type holding chamber containing 
ACSF (119 mM NaCl, 2.5 mM KCl, 1 mM NaH2PO4, 11 mM glucose, 
26 mM NaHCO3, 4 mM MgCl2, and 4 mM CaCl2) gassed with 95% 
O2 and 5% CO2. Control slices were incubated with ACSF alone (no ve-
hicle control is needed because both Chol Ox and MBCD are dissolved in 
water). Some slices had a recovery period after treatment, by incubating 
them with ACSF alone for an additional 1 h. Dissociated primary neuro-
nal cultures were incubated with 10 U/ml Chol Ox or 10 mM MBCD in 
culture medium for 30 min at 37°C. Controls were incubated with culture 
medium alone.
Cholesterol addition. Cholesterol–MBCD complexes were obtained 
by adding 30 µl of 50-mg/ml cholesterol (Sigma-Aldrich) solubilized in a 
solution of methanol/chloroform 2:1 to 1 ml of 50-mg/ml MBCD dissolved 
in water. The mixture was incubated at 80°C with shaking until clearance 
of the solution. Methanol, chloroform, and water were removed by speed 
vacuum overnight. The pellet was then resuspended in 20 ml ACSF, and 
20 µl of 2-mg/ml cholesterol in 95% ethanol was added. This method is 
adapted from Klein et al. (1995).
Electrophysiology
Voltage-clamp whole-cell recordings were obtained from CA1 pyramidal 
neurons under visual guidance using fluorescence and transmitted light 
illumination. The recording chamber was perfused with ACSF gassed 
with 5% CO2/95% O2, supplemented with 4 µM 2-chloroadenosine, and 
maintained at 29°C. Patch recording pipettes (3–8 MΩ) were filled with 
115 mM cesium methanesulfonate, 20 mM CsCl, 10 mM Hepes, 2.5 mM 
MgCl2, 4 mM Na2ATP, 0.4 mM Na3GTP, 10 mM sodium phosphocreatine, 
and 0.6 mM EGTA, pH 7.25. For mIPSCs recordings, cesium methanesul-
fonate was replaced with the same concentration of CsCl. For rectification 
experiments, the patch recording pipette solution was supplemented with 
0.1 mM spermine. Synaptic responses were evoked with single voltage 
pulses (200 µs, ≤30 V) on Schaffer collaterals. Responses were collected 
at 60, +40, or 0 mV, as indicated, and averaged over 50–80 trials. 
AMPA/GABA ratios were obtained by evoking synaptic responses at 60 
and 0 mV holding potentials in the presence of the NMDAR antagonist 
AP5 (100 µM). For NMDA/GABA ratios, recordings were performed 
in the absence of Mg2+ and in the presence of 10 µM CNQX (AMPAR 
antagonist), at 60 mV for NMDAR responses, and at 0 mV for GABAAR 
responses. For NMDAR time course, recordings were performed in the 
absence of Mg2+ and in the presence of 10 µM CNQX and the GABAAR 
antagonist picrotoxin (100 µM). LTP was induced in CA1 neurons by pair-
ing 3 Hz presynaptic stimulation of the Schaffer collaterals with 0 mV post-
synaptic depolarization. Recordings of miniature responses (mEPSC and 
mIPSC) were performed from 14–16 d in vitro hippocampal neurons at 
60 mV in the presence of 1 µM tetrodotoxin, 100 µM AP5, and 100 µM 
picrotoxin (for mEPSCs) or 10 µM CNQX (for mIPSCs). Electrophysiological 
recordings and data acquisition were performed with Multiclamp 700A/B 
amplifiers and pClamp software (Molecular Devices). Analysis was per-
formed with pClamp software (miniature currents) or custom-made Excel 
(Microsoft) macros (supplemental material).
Immunocytochemistry
Neurons were fixed with 4% paraformaldehyde and 4% sucrose in PBS for 
10 min at room temperature. Nonspecific binding was blocked with 0.2% 
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